Compile Data Set for Download or QSAR
Report error Found 41 Enz. Inhib. hit(s) with all data for entry = 50006844
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503838(CHEMBL4450704)
Affinity DataIC50: 10nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503834(CHEMBL4591009)
Affinity DataIC50: 17nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503827(CHEMBL4439652)
Affinity DataIC50: 17nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503822(CHEMBL4460788)
Affinity DataIC50: 19nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503841(CHEMBL4554040)
Affinity DataIC50: 20nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503835(CHEMBL4524341)
Affinity DataIC50: 21nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503838(CHEMBL4450704)
Affinity DataIC50: 22nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503822(CHEMBL4460788)
Affinity DataIC50: 23nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503832(CHEMBL4514344)
Affinity DataIC50: 26nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503837(CHEMBL4516721)
Affinity DataIC50: 27nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503823(CHEMBL4452698)
Affinity DataIC50: 28nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503841(CHEMBL4554040)
Affinity DataIC50: 29nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503823(CHEMBL4452698)
Affinity DataIC50: 30nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503840(CHEMBL4551742)
Affinity DataIC50: 34nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503825(CHEMBL4564494)
Affinity DataIC50: 34nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503827(CHEMBL4439652)
Affinity DataIC50: 34nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503824(CHEMBL4457957)
Affinity DataIC50: 35nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503833(CHEMBL4472308)
Affinity DataIC50: 35nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503840(CHEMBL4551742)
Affinity DataIC50: 36nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503834(CHEMBL4591009)
Affinity DataIC50: 38nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503832(CHEMBL4514344)
Affinity DataIC50: 42nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503839(CHEMBL4463348)
Affinity DataIC50: 46nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503842(CHEMBL4439673)
Affinity DataIC50: 54nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503826(CHEMBL4436171)
Affinity DataIC50: 55nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503830(CHEMBL4437509)
Affinity DataIC50: 55nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503837(CHEMBL4516721)
Affinity DataIC50: 64nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503830(CHEMBL4437509)
Affinity DataIC50: 69nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503831(CHEMBL4591916)
Affinity DataIC50: 74nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503833(CHEMBL4472308)
Affinity DataIC50: 74nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503824(CHEMBL4457957)
Affinity DataIC50: 81nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503828(CHEMBL4471283)
Affinity DataIC50: 84nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503828(CHEMBL4471283)
Affinity DataIC50: 111nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503836(CHEMBL4462515)
Affinity DataIC50: 176nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503825(CHEMBL4564494)
Affinity DataIC50: 200nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503826(CHEMBL4436171)
Affinity DataIC50: 281nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503842(CHEMBL4439673)
Affinity DataIC50: 322nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503831(CHEMBL4591916)
Affinity DataIC50: 354nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503821(CHEMBL4447643)
Affinity DataIC50: 798nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503821(CHEMBL4447643)
Affinity DataIC50: 1.17E+3nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503829(CHEMBL4460379)
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 1 hr in presence of [14C]-methyl-al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50503829(CHEMBL4460379)
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in sodium-dependent glucose uptake after 30 mins in presence of [14C]-methyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed